SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000897101-22-000114
Filing Date
2022-02-14
Accepted
2022-02-14 17:20:37
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G AMENDMENT NO. 5 cullen220184_13ga.htm SC 13G/A 49003
  Complete submission text file 0000897101-22-000114.txt   50497
Mailing Address 712 VISTA BLVD #305 WACONIA MN 55387
Business Address 712 VISTA BLVD #305 WACONIA MN 55387 9524791196
Panbela Therapeutics, Inc. (Subject) CIK: 0001029125 (see all company filings)

IRS No.: 870543922 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88985 | Film No.: 22634943
SIC: 2834 Pharmaceutical Preparations

Mailing Address 712 VISTA BLVD, #305 WACONIA MN 55387
Business Address
Cullen Michael T. (Filed by) CIK: 0001652996 (see all company filings)

Type: SC 13G/A